ProShares UltraShort Nasdaq Biotechnology (BIS) Chart & Stock Price History $19.07 +0.55 (+2.95%) As of 04/25/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartDividendHoldingsOptions ChainOwnershipShort InterestTrendsBuy This Stock ProShares UltraShort Nasdaq Biotechnology Stock Price Performance 5 Day Performance-0.78%1 Month Performance+6.36%3 Month Performance+15.10%6 Month Performance+25.07%Year-To-Date Performance+4.78%1 Year Performance-5.83% Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. Email Address BIS Stock Chart for Monday, April, 28, 2025 BIS Chart by TradingView ProShares UltraShort Nasdaq Biotechnology Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2025$18.52$19.06+2.92%$19.27$18.794,460 shs$3.24 million04/24/2025$19.21$18.52-3.59%$19.36$18.523,504 shs$3.15 million04/23/2025$19.82$19.21-3.08%$19.34$19.002,773 shs$3.84 million04/22/2025$20.91$19.82-5.21%$20.42$19.8213,936 shs$3.96 million04/21/2025$20.74$20.91+0.84%$21.24$20.474,362 shs$4.18 million04/18/2025$20.74$20.74$21.05$20.552,528 shs$4.15 million04/17/2025$20.97$20.74-1.12%$21.05$20.552,528 shs$4.15 million04/16/2025$20.21$20.97+3.76%$21.41$20.575,510 shs$4.19 million04/15/2025$20.10$20.21+0.55%$20.47$19.948,369 shs$4.04 million04/14/2025$21.38$20.10-5.99%$20.94$19.8818,382 shs$4.02 million Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 04/11/2025$22.88$21.38-6.56%$22.89$21.3326,332 shs$4.06 million04/10/2025$21.27$22.88+7.57%$24.19$21.8113,163 shs$4.35 million04/09/2025$23.85$21.27-10.82%$25.87$21.2322,647 shs$4.04 million04/09/2025$23.85$21.27-10.82%$25.87$21.2322,647 shs$4.04 million04/08/2025$22.36$23.85+6.66%$24.22$21.1613,354 shs$4.53 million04/08/2025$22.36$23.85+6.66%$24.22$21.1613,354 shs$4.53 million04/07/2025$21.81$22.36+2.52%$23.89$21.0333,175 shs$4.27 million04/04/2025$19.65$21.81+10.99%$21.81$20.3530,497 shs$4.14 million04/03/2025$18.95$19.65+3.69%$19.66$19.454,829 shs$3.73 million04/02/2025$19.68$18.95-3.71%$19.25$18.9213,773 shs$3.79 million04/01/2025$18.64$19.68+5.58%$19.68$18.6610,903 shs$3.94 million03/31/2025$17.92$18.64+4.02%$19.35$18.5716,906 shs$3.73 million03/28/2025$17.63$17.92+1.65%$18.03$17.778,613 shs$3.58 million03/27/2025$17.73$17.63-0.57%$17.65$17.494,081 shs$3.53 million Related Companies JPMorgan Healthcare Leaders ETF Stock Chart First Trust Nasdaq Pharmaceuticals ETF Stock Chart Horizon Kinetics Medical ETF Stock Chart Global X HealthTech ETF Stock Chart Invesco Nasdaq Biotechnology ETF Stock Chart ProShares Ultra Nasdaq Biotechnology Stock Chart F/m Emerald Life Sciences Innovation ETF Stock Chart Invesco Dorsey Wright Healthcare Momentum ETF Stock Chart Invesco S&P SmallCap Health Care ETF Stock Chart VanEck Biotech ETF Stock Chart Receive BIS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BIS) was last updated on 4/28/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BIS Stock Free BIS Stock Alerts